TCS, HDFCBANK, SBI Liquid Fund (G)
Marksans Pharma Ltd.
Marksans Pharma
NSE
₹ 0.00
0.00 (0.00)%
Healthcare
Small-cap
With a market cap of ₹18.90L Cr.
Moderate Volatility
Stock is 1.13x as volatile as index
| EX-Date | Purpose |
|---|---|
| 31 05 2021 | Final Dividend & Audited Results |
| 15 06 2021 | Issue Of Warrants |
| 23 07 2021 | Issue Of Warrants |
| 11 08 2021 | Quarterly Results |
| 09 11 2021 | Quarterly Results |
| 10 11 2021 | Quarterly Results (Revised) |
| 11 02 2022 | Quarterly Results |
| 30 05 2022 | Audited Results & Final Dividend |
| 08 07 2022 | Buy Back of Shares |
| 13 08 2022 | Quarterly Results |
| 14 11 2022 | Quarterly Results |
| 20 01 2023 | Inter alia, to consider and approve allotment of fully paid-up Equity Shares having face value of Re. 1/- each against the convertible warrants on preferential basis. |
| 13 02 2023 | Quarterly Results |
| 30 05 2023 | Final Dividend & Audited Results |
| 11 08 2023 | Quarterly Results |
| 09 11 2023 | Quarterly Results |
| 13 02 2024 | Quarterly Results |
| 12 11 2024 | Quarterly Results |
| 11 02 2025 | Quarterly Results |
News
No News data available
